Abstract:BACKGROUND:There are two completely contradictory views regarding the impact of human bone-marrow-derived mesenchymal stem cells (hMSCs) on hepatocellular carcinomas (HCCs). The aim of this study was to investigate the effect of hMSC engraftment on HCC tissues in nude mouse models, and assess the effect on metastatic potential of HCC.METHODS:hMSCs were engrafted into the nude mouse models of high metastatic HCC via the tail vein. The mice in the experimental group were engrafted with hMSCs (5 × 105 cells per mouse) via the tail vein 15 days after inoculation of tumor cells, twice a week, while the animals in the control group were injected with hMSC culture medium (0.2 mL per mouse) via the tail vein. The subcutaneous tumor size was measured using an electronic digital caliper once every 4 days after hMSC engraftment. After 2, 3, 4, 5 and 6 weeks of tumor cell inoculation, the mice were killed and the tumors were collected in their entirety. The tumor weights and body weights of mice were measured, and the tumor inhibition rate was calculated. Quantitative real-time polymerase chain reaction (RT-PCR) was used to determine the expression of metastasis-related genes including osteopontin (OPN), bone sialoprotein (BSP) and integrin α5 subunit (α-V) in the mouse models of high-metastatic HCC, and the expression of apoptosis-related genes including B cell lymphoma/leukemia-2 (Bcl2), Bcl-2 associated X protein (Bax) and caspase 3 in tumor samples.RESULTS:The tumor weight inhibition rate was 26.62% at 2 weeks, 52.00% at 3 weeks, 38.20% at 4 weeks, 31.98% at 5 weeks, and 30.23% at 6 weeks. Tumor tissue weight comparison results were significantly lower in the hMSC engraftment groups than in the control group at the second and third weeks. The expression of metastasis-related factors OPN, BSP and α-V gene was downregulated with time. The expression of antiapoptotic gene Bcl2 exhibited an obvious declining tendency, while the expression of apoptotic genes Bax and caspase 3 showed an obvious rising tendency. The expression of α-V and BSP significantly correlated positively with the expression of Bcl2, and negatively correlated with the expression of Bax and caspase 3. The tumor inhibition rate was not significantly correlated with the expression of antiapoptotic and apoptotic factors, and α-V and BSP factors, though it exhibited a significantly negative correlation with the expression of OPN.CONCLUSIONS:The highest tumor inhibition rate was observed 3 weeks after hMSCs engraftment, and the tumor inhibition rate gradually reduced with the progression of time. The metastatic potential of tumor cells was downregulated after hMSC engraftment and hMSCs induce further tumor cells apoptosis. The decrease in the proliferation ability of tumor cells may induce a decline in metastatic potential in tumor cells.

Overexpression of Hepatocyte Nuclear Factor 4α in Human Mesenchymal Stem Cells Suppresses Hepatocellular Carcinoma Development Through Wnt/β-catenin Signaling Pathway Downregulation.

Hepatic Stellate Cells Promote the Progression of Hepatocellular Carcinoma Through Microrna-1246-rorα-wnt/β-catenin Axis

Suppression of Tumorigenesis by Human Mesenchymal Stem Cells in a Hepatoma Model

Human Mesenchymal Stem Cells Inhibit Metastasis of a Hepatocellular Carcinoma Model Using the MHCC97‐H Cell Line

Exosomal Microrna-15A from Mesenchymal Stem Cells Impedes Hepatocellular Carcinoma Progression Via Downregulation of SALL4.

Hepatocyte Nuclear Factor 4 Alpha Suppresses the Development of Hepatocellular Carcinoma

Human mesenchymal stem cells overexpressing pigment epithelium-derived factor inhibit hepatocellular carcinoma in nude mice

Inhibitory Effect and Mechanism of Mesenchymal Stem Cells on Liver Cancer Cells

Tumor and Stem Cell Biology BMP 4 Administration Induces Differentiation of CD 133 þ Hepatic Cancer Stem Cells , Blocking Their Contributions to Hepatocellular Carcinoma

Data from BMP4 Administration Induces Differentiation of CD133+ Hepatic Cancer Stem Cells, Blocking Their Contributions to Hepatocellular Carcinoma

Mesenchymal stromal cells induce inhibitory effects on hepatocellular carcinoma through various signaling pathways

What is the Relationship among Microrna-181, Epithelial Cell-Adhesion Molecule (epcam) and Beta-Catenin in Hepatic Cancer Stem Cells

Human mesenchymal stem cells promote tumor growth via MAPK pathway and metastasis by epithelial mesenchymal transition and integrin α5 in hepatocellular carcinoma

Overexpression of hepatocyte nuclear factor 4αin umbilical cord mesenchymal stem cells promotes liver regeneration after subtotal hepatectomy in mice

Effect of Bone-Marrow-derived Mesenchymal Stem Cells on High-Potential Hepatocellular Carcinoma in Mouse Models: an Intervention Study

Mesenchymal Stem Cells In Inflammation Microenvironment Accelerates Hepatocellular Carcinoma Metastasis By Inducing Epithelial-Mesenchymal Transition

Hepatocyte Nuclear Factor 4 Alpha-Nuclear Factor-Kappa B Feedback Circuit Modulates Liver Cancer Progression

Involvement of Wnt/β-catenin Signaling in the Mesenchymal Stem Cells Promote Metastatic Growth and Chemoresistance of Cholangiocarcinoma

Differentiation Therapy of Hepatocellular Carcinoma in Mice with Recombinant Adenovirus Carrying Hepatocyte Nuclear Factor-4 Alpha Gene

Effects of transforming growth factor β-1 infected human bone marrow mesenchymal stem cells on high- and low-metastatic potential hepatocellular carcinoma

MicroRNA-6838-5p Suppresses the Self-Renewal and Metastasis of Human Liver Cancer Stem Cells Through Downregulating CBX4 Expression and Inactivating ERK Signaling